Updates from The Motley Fool

Latest updates on Rexahn Pharmaceuticals from Fool.com.

Stock Performance

RNN vs. S&P 500 | 2 Year Performance
RNN 1-Day Stock Chart
RNN 5-Day Stock Chart
RNN 1-Month Stock Chart
RNN 3-Month Stock Chart
RNN 6-Month Stock Chart
RNN 1-Year Stock Chart
RNN 2-Year Stock Chart
RNN 5-Year Stock Chart
View Interactive RNN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Rexahn Pharmaceuticals.
Current Price: $0.29
Prev Close: $0.28
Open: $0.29
Bid: $0.23
Ask: $0.35
Day's Range: $0.28 - $0.29
52wk Range: $0.25 - $0.77
Volume: 229,840
Avg Vol 482,953
Market Cap: $52.33M
P/E (ttm): -3.56
EPS (ttm): -$0.08
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Rexahn Pharmaceuticals.
CAPS Rating 3 out of 5
87 Outperform
14 Underperform
CAPS All Stars
7 Outperform
6 Underperform

How do you think Rexahn Pharmaceuticals will perform against the market?

You pick for Rexahn Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

Business Summary

Industry, sector and description for Rexahn Pharmaceuticals.

Rexahn Pharmaceuticals Inc. is a clinical stage biopharmaceutical company developing and seeking to deliver novel cures for cancer and disorders of the central nervous system (CNS) to patients worldwide.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Drug Makers